The DOI matches its Crossref record; 58 of the 61 references it cites were found in a registry or an index.
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function
Open accessAbstract
BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The purified 130-kDa protein was subject to tandem mass spectrometry and the FANCJ gene was cloned and found to consist of 20 exons spanning greater than 180 kb of genomic sequence in chromosome 17q22.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Furthermore, unlike the classic paradigm for tumor suppressor genes, in which the tumor exclusively lacks the wild-type allele, tumors of individuals who were heterozygous for these two germline FANCJ mutations did not show loss of the corresponding wild-type allele [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Most notably, the protein product had strong homology to the catalytic and nucleotide-binding domains of other members within the DEAH helicase family, including the xeroderma pigmentosum complimenting group D (XPD) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In keeping with this suggestion, two patients with a family history and early-onset breast cancer were identified that had discrete germline sequence changes, P47A and M299I, targeting the helicase domain of FANCJ [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Moreover, the aforementioned P47A mutant had a reduced protein half-life when overexpressed in tissue culture cells [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In particular, overexpression of the helicase-inactive K52R mutant in cells with wild-type FANCJ resulted in the accumulation of unrepaired DNA breaks when analyzed by pulse field electrophoresis [8], as well as reduced homologous recombination following double strand break induction [69].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“BRCA1 clinical mutations target the BRCT region required for FANCJ binding [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Self-citationDynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citation
Research works printed but not linked: 1
- Ma, 1994, Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation, Mol. Cell. Biol., 14, 4126, 10.1128/MCB.14.6.4126 · DOI
Cited by
Sorted by citations
Items 301–400 of 676
Rescue of replication failure by Fanconi anaemia proteins
Constantinou, A. (2011) · Chromosoma · doi:10.1007/s00412-011-0349-2 · Cited by 40
A requirement of FancL and FancD2 monoubiquitination in DNA repair
Seki, S., Ohzeki, M., Uchida, A., Hirano, S., Matsushita, N., Kitao, H., Oda, T., Yamashita, T., Kashihara, N., Tsubahara, A., et al. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01054.x · Cited by 35
Sommers, J. A., Banerjee, T., Hinds, T., Wan, B., Wold, M. S., Lei, M., & Brosh, R. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542456 · Cited by 35
The BARD1 C-Terminal Domain Structure and Interactions with Polyadenylation Factor CstF-50
Edwards, R. A., Lee, M.-S., Tsutakawa, S. E., Williams, R. S., Nazeer, I., Kleiman, F. E., Tainer, J. A., & Glover, J. N. (2008) · Biochemistry · doi:10.1021/bi801115g · Cited by 34
O’Neil, N. J. (2006) · WormBook · doi:10.1895/wormbook.1.54.1 · Cited by 34
Nath, S., & Nagaraju, G. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008701 · Cited by 34
Cancer-associated mutations in the iron-sulfur domain of FANCJ affect G-quadruplex metabolism
Odermatt, D. C., Lee, W. T. C., Wild, S., Jóźwiakowski, S. K., Rothenberg, E., & Gari, K. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008740 · Cited by 35
Breast Cancer Predisposition Genes and Synthetic Lethality
Neiger, H. E., Siegler, E. L., & Shi, Y. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115614 · Cited by 33
Awate, S., & Brosh, R. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061233 · Cited by 32
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
Frank, B., Hemminki, K., Meindl, A., Wappenschmidt, B., Sutter, C., Kiechle, M. B., Bugert, P., Schmutzler, R. K., Bartram, C. R., & Burwinkel, B. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-83 · Cited by 34
Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women
Huo, X., Lu, C., Huang, X., Hu, Z., Jin, G., Ma, H., Wang, X., Qin, J., Wang, X., Shen, H., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0604-6 · Cited by 32
BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work
Bracci, M., Ciarapica, V., Elexpuru-Zabaleta, M., Tartaglione, M. F., Pirozzi, S., Giuliani, L., Piva, F., Valentino, M., Ledda, C., Rapisarda, V., et al. (2019) · Cancers · doi:10.3390/cancers11081146 · Cited by 32
Watanabe, Y., Maeda, I., Oikawa, R., Wu, W., Tsuchiya, K., Miyoshi, Y., Itoh, F., Tsugawa, K., & Ohta, T. (2013) · Genes to Cells · doi:10.1111/gtc.12100 · Cited by 32
Helicase-inactivating mutations as a basis for dominant negative phenotypes
Wu, Y., & Brosh, R. M. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13667 · Cited by 31
Litim, N., Labrie, Y., Desjardins, S., Ouellette, G., Plourde, K. V., Belleau, P., BRCAs, I., & Durocher, F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.08.002 · Cited by 32
C. elegans as a model organism to study female reproductive health
Athar, F., & Templeman, N. M. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111152 · Cited by 34
Male Breast Cancer: From Molecular Genetics to Clinical Management
Pensabene, M., von Arx, C., & Laurentiis, M. D. (2022) · Cancers · doi:10.3390/cancers14082006 · Cited by 34
Thermodynamics of Phosphopeptide Tethering to BRCT: The Structural Minima for Inhibitor Design
Lokesh, G. L.-R., Muralidhara, B. K., Negi, S. S., & Natarajan, A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0739178 · Cited by 31
Lokesh, G. L.-R., Rachamallu, A., Kumar, G. D. K., & Natarajan, A. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.01.025 · Cited by 32
Lim, J.-H., Song, M., Cho, Y., Kim, W., Han, S. O., & Ryu, J. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.02.020 · Cited by 30
Homologous repair deficiency score for identifying breast cancers with defective DNA damage response
Min, A., Kim, K., Jeong, K., Choi, S., Kim, S., Suh, K. J., Lee, K.-H., Kim, S., & Im, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68176-y · Cited by 31
Spies, M. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.01.013 · Cited by 33
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
Silvestri, V., Rizzolo, P., Falchetti, M., Zanna, I., Masala, G., Bianchi, S., Palli, D., & Ottini, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1289-x · Cited by 32
BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220
Wada, O., Oishi, H., Takada, I., Yanagisawa, J., Yano, T., & Kato, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207786 · Cited by 30
RetractedFANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses
Zhang, F., Fan, Q., Ren, K., Auerbach, A. D., & Andreassen, P. R. (2010) · Chromosoma · doi:10.1007/s00412-010-0285-6 · Cited by 31
Dorn, A., Feller, L., Castri, D., Röhrig, S., Enderle, J., Herrmann, N. J., Block-Schmidt, A. S., Trapp, O., Köhler, L., & Puchta, H. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008174 · Cited by 30
Lo, S., Chernoff, H., Cong, L., Ding, Y., & Zheng, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805242105 · Cited by 30
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Cantor, S. B., & Xie, J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20568 · Cited by 29
Self-citationDas, S. P., & Sinha, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.034 · Cited by 29
Rewiring the dynamic interactome
Davis, M. J., Shin, C. J., Jing, N., & Ragan, M. A. (2012) · Molecular BioSystems · doi:10.1039/c2mb25050k · Cited by 31
Estep, K. N., & Brosh, R. M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170044 · Cited by 30
RAP80 phase separation at DNA double-strand break promotes BRCA1 recruitment
Qin, C., Wang, Y., Zhou, J., Shi, J., Zhao, W.-W., Zhu, Y., Bai, S.-M., Feng, L., Bie, S.-Y., Zeng, B., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad686 · Cited by 29
ACCA Phosphopeptide Recognition by the BRCT Repeats of BRCA1
Ray, H., Moreau, K., Dizin, É., Callebaut, I., & Venezia, N. D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.010 · Cited by 33
New Insights into Breast Cancer Genetics and Impact on Patient Management
Rosman, D. S., Kaklamani, V., & Pasche, B. (2007) · Current Treatment Options in Oncology · doi:10.1007/s11864-007-0021-5 · Cited by 28
Microfluidics: Rapid Diagnosis for Breast Cancer
Panesar, S., & Neethirajan, S. R. (2016) · Nano-Micro Letters · doi:10.1007/s40820-015-0079-8 · Cited by 30
Two Forms of Mitochondrial DNA Ligase III Are Produced inXenopus laevis Oocytes
Perez-Jannotti, R. M., Klein, S. M., & Bogenhagen, D. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107177200 · Cited by 29
No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast‐cancer families linked to 17q22
Luo, L., Lei, H., Du, Q., von Wachenfeldt, A., Kockum, I., Luthman, H., Vorechovsky, I., & Lindblom, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10214 · Cited by 28
Dissecting the chromatin interactome of microRNA genes
Chen, D., Fu, L.-Y., Zhang, Z., Li, G., Zhang, H., Li, J., Harrison, A., Shanahan, H. P., Klukas, C., Zhang, H., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1294 · Cited by 29
DNA- and DNA-Protein-Crosslink Repair in Plants
Enderle, J., Dorn, A., & Puchta, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174304 · Cited by 30
Pickholtz, I., Saadyan, S., Keshet, G. I., Wang, V. S., Cohen, R., Bouwman, P., Jonkers, J., Byers, S. W., Papa, M. Z., & Yarden, R. I. (2014) · Oncotarget · doi:10.18632/oncotarget.2582 · Cited by 32
Anisimov, V. M., Žiemys, A., Kizhake, S., Yuan, Z., Natarajan, A., & Cavasotto, C. N. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9484-3 · Cited by 29
The yin and yang of repair mechanisms in DNA structure-induced genetic instability
Vásquez, K. M., & Wang, G. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.11.005 · Cited by 28
FANCJ Localization by Mismatch Repair Is Vital to Maintain Genomic Integrity after UV Irradiation
Guillemette, S., Branagan, A. M., Peng, M., Dhruva, A., Schärer, O. D., & Cantor, S. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2474 · Cited by 28
Self-citationThe c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding
Millevoi, S., Bernat-Fabre, S., Telly, D., Fouque, F., Gladieff, L., Favre, G., Vagner, S., & Toulas, C. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0392-3 · Cited by 28
Judkins, T., Hendrickson, B. C., Deffenbaugh, A. M., & Scholl, T. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.024 · Cited by 28
BRCA1 Interacts with Poly(A)-binding Protein
Dizin, É., Gressier, C., Magnard, C., Ray, H., Décimo, D., Ohlmann, T., & Venezia, N. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602176200 · Cited by 28
No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families
Karppinen, S., Vuosku, J., Heikkinen, K., Allinen, M., & Winqvist, R. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00498-7 · Cited by 28
Beckta, J. M., Dever, S. M., Gnawali, N., Khalil, A. A., Sule, A. D., Golding, S. E., Rosenberg, E., Narayanan, A., Kehn‐Hall, K., Xu, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4876 · Cited by 26
Regulatory role of Non-canonical DNA Polymorphisms in human genome and their relevance in Cancer
Pandya, N., Bhagwat, S. R., & Kumar, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188594 · Cited by 29
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
Aranza-Martínez, A., Sánchez-Pérez, J., Brito-Elías, L., López‐Camarillo, C., de León, D. F. C., Pérez‐Plasencia, C., & López–Urrutia, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.752270 · Cited by 27
Keimling, M., Kaur, J., Bagadi, S. A. R., Kreienberg, R., Wiesmüller, L., & Ralhan, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23551 · Cited by 27
Gupta, I., Ouhtit, A., Al-Ajmi, A., Rizvi, S. G. A., Al‐Riyami, H., Al-Riyami, M., & Tamimi, Y. (2017) · Endocrine Connections · doi:10.1530/ec-17-0173 · Cited by 27
Gaiser, O. J., Ball, L., Schmieder, P., Leitner, D., Strauss, H. M., Wahl, M., Kühne, R., Oschkinat, H., & Heinemann, U. (2004) · Biochemistry · doi:10.1021/bi049550q · Cited by 27
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast1
Westmoreland, T. J., Olson, J. A., Saito, W. Y., Hüper, G., Marks, J. R., & Bennett, C. B. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00155-0 · Cited by 26
BRCA1 in breast and ovarian cancer predisposition
Billack, B., & Monteiro, Á. N. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.006 · Cited by 26
Nagaprashantha, L. D., Adhikari, R., Singhal, J., Chikara, S., Awasthi, S., Horne, D. A., & Singhal, S. S. (2017) · International Journal of Cancer · doi:10.1002/ijc.31085 · Cited by 26
BRCA1 the Versatile Defender: Molecular to Environmental Perspectives
Zhong, A. X., Chen, Y., & Chen, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814276 · Cited by 25
The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
Sundararajan, S., Ahmed, A. K., & Goodman, O. B. (2011) · PubMed · Cited by 25
Gough, C. A., Gojobori, T., & Imanishi, T. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21188 · Cited by 25
Chapter 5 Mechanisms of Sister Chromatid Pairing
Skibbens, R. V. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01005-8 · Cited by 23
The budding yeast protein Chl1p is required to preserve genome integrity upon DNA damage in S-phase
Laha, S., Das, S. P., Hajra, S., Sau, S., & Sinha, P. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl749 · Cited by 24
Tandem BRCT Domains: DNA's Praetorian Guard
Mesquita, R. D., Woods, N. T., Seabra-Junior, E. S., & Monteiro, Á. N. A. (2010) · Genes & Cancer · doi:10.1177/1947601910392988 · Cited by 26
Wang, J., Sun, D., Lu, W., Zhang, Z., Zhang, C., & Hu, K. (2020) · Experimental Physiology · doi:10.1113/ep088210 · Cited by 23
Calvo, J. A., Fritchman, B., Hernandez, D., Persky, N. S., Johannessen, C. M., Piccioni, F., Kelch, B. A., & Cantor, S. B. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0828 · Cited by 23
Self-citationAn emerging picture of FANCJ’s role in G4 resolution to facilitate DNA replication
Brosh, R. M., & Wu, Y. (2021) · NAR Cancer · doi:10.1093/narcan/zcab034 · Cited by 24
FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells
Cong, K., MacGilvary, N. J., Lee, S., MacLeod, S. G., Calvo, J. A., Peng, M., Kousholt, A. N., Day, T. A., & Cantor, S. B. (2024) · Nature Communications · doi:10.1038/s41467-024-46824-5 · Cited by 23
Self-citationChen, X., Wilson, J. B., McChesney, P. A., Williams, S. A., Kwon, Y., Longerich, S., Marriott, A. S., Sung, P., Jones, N. J., & Kupfer, G. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.552570 · Cited by 24
An MLH1 Mutation Links BACH1/FANCJ to Colon Cancer, Signaling, and Insight toward Directed Therapy
Xie, J., Guillemette, S., Peng, M., Gilbert, C. A., Buermeyer, A. B., & Cantor, S. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0118 · Cited by 23
Self-citationRegulation of various DNA repair pathways by E3 ubiquitin ligases
Natarajan, C., & Takeda, K. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.204879 · Cited by 25
Petrini, J. H. J. (2007) · Science · doi:10.1126/science.1143700 · Cited by 23
Laha, S., Das, S. P., Hajra, S., Sanyal, K., & Sinha, P. (2011) · BMC Genetics · doi:10.1186/1471-2156-12-83 · Cited by 23
Telomeres do the (un)twist: Helicase actions at chromosome termini
Chavez, A., Tsou, A. M., & Johnson, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.008 · Cited by 24
Mammalian DNA Damage Response Pathway
Lou, Z., & Chen, J. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_15 · Cited by 19
Exploiting the P-1 Pocket of BRCT Domains Toward a Structure Guided Inhibitor Design
Yuan, Z., Kumar, E. A., Campbell, S. J., Palermo, N. Y., Kizhake, S., Glover, J. N. M., & Natarajan, A. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200147a · Cited by 23
Sólyom, S., Pylkäs, K., & Winqvist, R. (2010) · Familial Cancer · doi:10.1007/s10689-010-9360-7 · Cited by 25
Getting Ready for the Dance: FANCJ Irons Out DNA Wrinkles
Bharti, S., Awate, S., Banerjee, T., & Brosh, R. M. (2016) · Genes · doi:10.3390/genes7070031 · Cited by 22
You, W., Huang, Y. M. M., Kizhake, S., Natarajan, A., & Chang, C. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005057 · Cited by 22
Zou, J., Zhang, D., Qin, G., Chen, X., Wang, H., & Zhang, D. (2014) · Cell Cycle · doi:10.4161/15384101.2014.964973 · Cited by 24
The Fanconi anemia protein interaction network: Casting a wide net
Rego, M. A., Kolling, F. W., & Howlett, N. G. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.018 · Cited by 22
Zou, J., Tian, F., Li, J., Pickner, W. J., Long, M., Rezvani, K. S., Wang, H., & Zhang, D. (2013) · Biology Open · doi:10.1242/bio.20135801 · Cited by 22
Thermal unfolding of human BRCA1 BRCT-domain variants
Nikolopoulos, G., Pyrpassopoulos, S., Thanassoulas, A., Klimentzou, P., Zikos, C. C., Vlassi, M., Vorgias, C. E., Yannoukakos, D., & Nounesis, G. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.03.018 · Cited by 21
BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan
Biunno, I., Aceto, G. M., Awadelkarim, K. D., Morgano, A., Elhaj, A., Eltayeb, E. A., Abuidris, D. O., Elwali, N. E., Spinelli, C., Blasio, P. D., et al. (2014) · Familial Cancer · doi:10.1007/s10689-014-9717-4 · Cited by 20
Vohhodina, J., Toomire, K. J., Petit, S. A., Micevic, G., Kumari, G., Botchkarev, V. V., Li, Z., Livingston, D. M., & Hu, Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908003117 · Cited by 22
Self-citationMaintenance of genome integrity by the late-acting cytoplasmic iron-sulfur assembly (CIA) complex
Petronek, M. S., & Allen, B. G. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1152398 · Cited by 23
DNA Helicases in NER, BER, and MMR
Kuper, J., & Kisker, C. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5037-5_10 · Cited by 20
Ma, X. D., Cai, G. Q., Zou, W., Huang, Y., Zhang, J. R., Wang, D. T., & Chen, B. L. (2013) · Gene · doi:10.1016/j.gene.2013.04.025 · Cited by 20
Hampton, O. A., Miller, C. A., Koriabine, M., Li, J., den Hollander, P., Carbone, L., Nefedov, M. D., ten Hallers, B., Lee, A. V., de Jong, P. J., et al. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.009 · Cited by 18
BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution
Tsukada, K., Jones, S. E., Bannister, J. V., Durin, M.-A., Vendrell, I., Fawkes, M., Fischer, R., Kessler, B. M., Chapman, J. R., & Blackford, A. N. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.040 · Cited by 18
FancJ/Brip1 helicase protects against genomic losses and gains in vertebrate cells
Kitao, H., Nanda, I., Sugino, R. P., Kinomura, A., Yamazoe, M., Arakawa, H., Schmid, M., Innan, H., Hiom, K. J., & Takata, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01523.x · Cited by 20
BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity
Zou, W., Ma, X., Hua, W., Chen, B., Huang, Y., Wang, D., & CAI, G. (2015) · Oncology Letters · doi:10.3892/ol.2015.3963 · Cited by 19
Wu, C. G., & Spies, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5037-5_1 · Cited by 19
DNA Helicases as Safekeepers of Genome Stability in Plants
Dorn, A., & Puchta, H. (2019) · Genes · doi:10.3390/genes10121028 · Cited by 19
Real-time Investigation of SV40 Large T-antigen Helicase Activity Using Surface Plasmon Resonance
Plyler, J. R., Jasheway, K. R., Tuesuwan, B., Karr, J. R., Brennan, J., Kerwin, S. M., & David, W. M. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9038-z · Cited by 19
BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
Laha, S., Katheeja Muhseena, N., Das, R., & Das, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1035052 · Cited by 19
The Fanconi anemia pathway: Insights from somatic cell genetics using DT40 cell line
Takata, M., Ishiai, M., & Kitao, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.012 · Cited by 18
Sommers, J. A., Suhasini, A. N., & Brosh, R. M. (2015) · Biomolecules · doi:10.3390/biom5020590 · Cited by 19
Discovery of cell-type specific DNA motif grammar in cis-regulatory elements using random Forest
Wang, X., Lin, P., & Ho, J. W. K. (2018) · BMC Genomics · doi:10.1186/s12864-017-4340-z · Cited by 18
Functional Impacts of the BRCA1-mTORC2 Interaction in Breast Cancer
Krieger, K. L., Hu, W., Ripperger, T. J., & Woods, N. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235876 · Cited by 18
Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies
Voutsadakis, I. A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i11.1197 · Cited by 18
The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data
Gianni, P., Matenoglou, E., Geropoulos, G., Agrawal, N., Adnani, H., Zafeiropoulos, S., Miyara, S. J., Guevara, S., Mumford, J. M., Molmenti, E. P., et al. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.08.001 · Cited by 18
Metadata
- Authors
- Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Livingston, David M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 105
- Issue
- 1
- Pages
- 149-160
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2109173575
- Cited by
- 674
- References
- 61
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 20 · 2023: 25 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 14 · 2017: 20 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 21 · 2012: 35
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007627, T32-HL07627-16)
- National Cancer Institute (P50 CA 89393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, protein-protein interaction, DNA double-strand break repair, homologous recombination, germline mutations, early-onset breast cancer, cancer susceptibility genes
- MeSH terms
- Adult, Binding Sites, Boston, Breast Neoplasms, Cell Line, Chromosomes, Human, Pair 17, DNA Repair, DNA Helicases, DNA-Binding Proteins, Female, Genetic Testing, Humans, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, Amino Acid Motifs, Spectrometry, Mass, Electrospray Ionization, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
